Specialist advisory support across the CDD process
Our expert team, with over 90 years of combined industry experience, provides thorough commercial due diligence (CDD) to help you make informed decisions. The CDD process involves a comprehensive analysis of a target company's business model, market position, and competitive landscape, evaluating customer base, revenue streams, market trends, and overall growth potential. Conducting CDD is crucial before buying a company, as it offers valuable insights into the target's strengths and weaknesses.
By working with us during this step, we provide expert analysis to ensure buyers understand the business's true value, mitigate potential risks, and identify strategic growth opportunities post-acquisition. This comprehensive approach helps buyers make informed decisions and enhances the success of their investments.
Our Expertise
Our team combines biotech industry knowledge with commercial experience and scientific understanding. We offer personalised advisory support, and have regular meetings with clients - communication is key. Our expertise spans antibodies, antigens, proteins, assays, genetics, molecular biology, and IVD market. Our team will assess the science, IP, and processes of your target, identifying risks, strengths, opportunities, and synergies. This enables us to generate recommendations during the CDD process ensuring, clients can move forward with a clear strategy.
We offer a complementary view to larger consultancies from the perspective of technical and operational knowledge to enhance your decision-making process.
Our Comprehensive CDD Process
Specialist advisory support across the CDD process – comprehensive support to private equity, banks, corporates and larger consultancies on acquisitions, mergers, disposals & integrations
Strategic Assessment
- In-depth review of Confidential Information Memoranda (CIMs)
- Buy, build and grow strategies
- Go-to-market review
- SWOT analysis
- Market opportunity
Integration
- Future organic and inorganic expansion
- Synergies and synergy potential
- Personnel and organisational assessment
- Integration strategies/roadmap generation post-acquisition
Technical Assessment
- Technical expansion
- Synergies and synergy potential
- Competitive landscape & market positioning
- Technology deep dives
- Confidential 3rd party expert interviews
A delighted customer of Pivotal Scientific's consulting services
I would like to share my experience as a delighted customer of Pivotal Scientific’s consulting services. From the start of the project, the PSL team showed great skill in the antibody market. They often exceeded my expectations with their smart industry knowledge and creative ideas.
Throughout the completion of the project, Tim, Stevan and Sian consistently delivered exceptional results. Their meticulous attention to detail ensured that each project phase was completed successfully and on time.
What truly sets them apart is their ability to not only meet but exceed expectations. Their team didn’t just meet the project requirements. They also brought valuable industry insights and fresh ideas. This improved the quality of our results.
One of the standout services I found helpful was their Antibody Market Report. This detailed report gave me a clear view of the antibody market. It helped me understand the complexities and make better decisions. It was instrumental in helping me grasp the nuances of the market and identify lucrative opportunities for the business.
Their dedication, professionalism, and knowledge have made them my top choice for consulting in the antibody market. I highly recommend their services to anyone seeking unparalleled expertise and exceptional results. With Pivotal Scientific, you’re not just getting a service provider. You’re gaining a trusted partner who is dedicated to your success.
Trust me, you won’t be disappointed!
The Pivotal Advantage
Combining our scientific knowledge with operational industry knowledge, we advise on all technical and operational aspects of a target company, integration, synergies, technical expansion, buy and grow strategies.
- External review and report on Confidential Information Memoranda (CIMs)
- Full commercial analysis of an organization – people, product, sales, marketing
- Strategic assessment of the opportunity and synergies
- Assessment of market opportunity
- In-depth assessment of the technology and science – benefits, product development, uniqueness, gaps and potential
- Confidential 3rd party expert interviews – Voice of customer, supplier, distributor
